Financing
Payments Of Deferred Offering Costs
Revolution Medicines, Inc. Payments Of Deferred Offering Costs increased by 231.9% to $252.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1300.0%, from $18.00K to $252.00K. Over 4 years (FY 2021 to FY 2025), Payments Of Deferred Offering Costs shows a downward trend with a -15.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ1 2019
Last reportedQ1 2026May 6, 2026
How to read this metric
Higher payments indicate significant capital-raising activity, though these costs are generally expected to be minimized.
Detailed definition
This metric records the cash outflows for costs directly attributable to a planned or completed equity or debt offering,...
Peer comparison
Standard for any company frequently accessing capital markets.
Metric ID:
financing_payments_of_deferred_offering_costs_20a061Historical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $106.00K | $106.00K | $106.00K | -$10.50K | -$10.50K | -$10.50K | -$10.50K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$284.00K | $18.00K | -$2.00K | -$45.00K | -$191.00K | $252.00K |
| QoQ Change | — | +0.0% | +0.0% | -109.9% | +0.0% | +0.0% | +0.0% | +100.0% | — | — | — | — | — | — | — | +106.3% | -111.1% | <-999% | -324.4% | +231.9% |
| YoY Change | — | — | — | — | -109.9% | -109.9% | -109.9% | +100.0% | +100.0% | +100.0% | +100.0% | — | — | — | — | — | — | — | +32.7% | >999% |
Range-$284.00K – $252.00K
CAGR+20.0%
Avg YoY Growth+155.9%
Median YoY Growth+100.0%
Payments Of Deferred Offering Costs at Other Companies
Frequently Asked Questions
- What is Revolution Medicines, Inc.'s payments of deferred offering costs?
- Revolution Medicines, Inc. (RVMD) reported payments of deferred offering costs of $252.00K in Q1 2026.
- How has Revolution Medicines, Inc.'s payments of deferred offering costs changed year-over-year?
- Revolution Medicines, Inc.'s payments of deferred offering costs increased by 1300.0% year-over-year, from $18.00K to $252.00K.
- What is the long-term trend for Revolution Medicines, Inc.'s payments of deferred offering costs?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s payments of deferred offering costs has grown at a -15.1% compound annual growth rate (CAGR), from $424.00K to -$220.00K.
- What does payments of deferred offering costs mean?
- Cash spent on fees related to preparing for or executing a stock or debt offering.